CGGO's competitive 0.47% expense ratio and active management aim for outperformance ... CGGO will make more and more sense as a core allocation. Get 50% Off The Lead-Lag Report Are you tired of being ...
Revenues in the fiscal second quarter of 2025 decreased 3% to $201,000, largely due to decreased sales to veterinary clinics. The decrease was partially offset by a 24% increase in sales to ...
Departments report a need for affordable, integrated solutions rather than fragmented technologies ... and apply appropriate tactical use-of-force measures to better perform in the field. By offering ...
bluebird bio, Inc. (NASDAQ: BLUE) (“bluebird bio” or the “Company”) today reported third quarter results and business highlights for the quarter ended September 30, 2024, including recent commercial ...